Connection

Co-Authors

This is a "connection" page, showing publications co-authored by JUN TERUYA and VADIM KOSTOUSOV.
Connection Strength

4.710
  1. How to best monitor bivalirudin anticoagulant effect for ECMO and VAD-Comparison of four assay methods. Int J Lab Hematol. 2022 Jun; 44(3):589-594.
    View in: PubMed
    Score: 0.807
  2. C-reactive protein-induced activated partial thromboplastin time prolongation in heparinized samples is attenuated by elevated factor VIII. Int J Lab Hematol. 2021 Feb; 43(1):139-142.
    View in: PubMed
    Score: 0.736
  3. Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing. Thromb Res. 2020 02; 186:54-57.
    View in: PubMed
    Score: 0.701
  4. The influence of free hemoglobin and bilirubin on heparin monitoring by activated partial thromboplastin time and anti-Xa assay. Arch Pathol Lab Med. 2014 Nov; 138(11):1503-6.
    View in: PubMed
    Score: 0.492
  5. Bivalirudin Stability in Citrated Plasma and Citrated Whole Blood. Arch Pathol Lab Med. 2024 Jan 01; 148(1):11-12.
    View in: PubMed
    Score: 0.232
  6. Is it time to switch to bivalirudin for ECMO anticoagulation? Front Med (Lausanne). 2023; 10:1237601.
    View in: PubMed
    Score: 0.226
  7. The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation. Semin Thromb Hemost. 2024 Feb; 50(1):81-90.
    View in: PubMed
    Score: 0.218
  8. Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation. Crit Care Explor. 2022 Oct; 4(10):e0776.
    View in: PubMed
    Score: 0.214
  9. Trimester-specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state. Int J Lab Hematol. 2021 Oct; 43(5):1216-1224.
    View in: PubMed
    Score: 0.190
  10. Low antithrombin levels in neonates and infants undergoing congenital heart surgery result in more red blood cell and plasma transfusion on cardiopulmonary bypass. Transfusion. 2020 12; 60(12):2841-2848.
    View in: PubMed
    Score: 0.185
  11. Does rotational thromboelastometry accurately predict coagulation status in patients with lupus anticoagulant? Int J Lab Hematol. 2018 Oct; 40(5):521-526.
    View in: PubMed
    Score: 0.157
  12. Management of Hemostasis for Pediatric Patients on Ventricular-Assist Devices. Semin Thromb Hemost. 2018 Feb; 44(1):30-37.
    View in: PubMed
    Score: 0.152
  13. Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation. Semin Thromb Hemost. 2018 Feb; 44(1):20-29.
    View in: PubMed
    Score: 0.150
  14. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014 Jun; 15(5):e198-205.
    View in: PubMed
    Score: 0.120
  15. Structural characterization of a clinically described heparin-like substance in plasma causing bleeding. Carbohydr Polym. 2020 Sep 15; 244:116443.
    View in: PubMed
    Score: 0.045
  16. Tortuosity-powered microfluidic device for assessment of thrombosis and antithrombotic therapy in whole blood. Sci Rep. 2020 04 01; 10(1):5742.
    View in: PubMed
    Score: 0.045
  17. ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes. Pediatr Transplant. 2018 11; 22(7):e13263.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.